Integrin β4 as a Potential Diagnostic and Therapeutic Tumor Marker

Biomolecules. 2021 Aug 12;11(8):1197. doi: 10.3390/biom11081197.

Abstract

Integrin β4 (ITGβ4) is a class of transmembrane adhesion molecules composed of hemidesmosomes (HDs). Its unique long intracellular domain provides intricate signal transduction functions. These signal transduction effects are especially prominent in tumors. Many recent studies have shown that integrin β4 is differentially expressed in various tumors, and it plays a vital role in tumor invasion, proliferation, epithelial-mesenchymal transition, and angiogenesis. Therefore, we categorize the research related to integrin β4, starting from its structure and function in tumor tissues, and provide a basic description. Based on its structure and function, we believe that integrin β4 can be used as a tumor marker. In clinical practice, it is described as a diagnostic marker for the targeted treatment of cancer and will be helpful in the clinical diagnosis and treatment of tumors.

Keywords: cancer; diagnostic significance; integrin β4; prognostic significance; therapeutic target.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Biomarkers, Tumor / biosynthesis*
  • Biomarkers, Tumor / genetics
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Integrin beta4 / biosynthesis*
  • Integrin beta4 / genetics
  • Neoplasm Invasiveness / pathology
  • Neoplasms / diagnosis
  • Neoplasms / drug therapy*
  • Neoplasms / genetics
  • Neoplasms / metabolism*

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Integrin beta4